Literature DB >> 1704133

Rapid induction of the c-jun protooncogene in the avian oviduct by the antiestrogen tamoxifen.

C K Lau1, M Subramaniam, K Rasmussen, T C Spelsberg.   

Abstract

This report describes a rapid regulation of the expression of the c-jun protooncogene by the antiestrogen tamoxifen (Tam). The c-jun protooncogene codes for an important component of the AP-1 transcription factor complex, which regulates the expression of many unlinked genes. Repeated experiments have shown that Tam rapidly increases the steady-state c-jun mRNA levels in the avian oviduct but decreases the levels in the liver. The Tam effects are time- and dose-dependent. These results are supported by other studies that have demonstrated that 17 beta-estradiol decreases steady-state levels of c-jun protooncogene mRNA in oviducts of animals fully withdrawn from estradiol. The effect of Tam in the avian oviduct is in contrast to the reported effects of Tam on the expression of practically all other genes in the avian oviduct and other animal tissues. Transcription analyses using nuclear runoff experiments with oviduct nuclei demonstrate a decrease in the c-jun gene transcription within minutes after Tam treatment with a return to 75% of control values by 4 hr. The fact that Tam transiently decreases the transcription of the c-jun gene but increases the steady-state c-jun mRNA levels suggests that Tam must alter both transcriptional and post-transcriptional events. The results support a role of the c-jun protooncogene as a regulatory gene in the cascade model for steroid action whereby steroids rapidly regulate the regulatory genes, which in turn regulate many other structural genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704133      PMCID: PMC50907          DOI: 10.1073/pnas.88.3.829

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 2.  Ovarian steroid action on gene expression: mechanisms and models.

Authors:  C Rories; T C Spelsberg
Journal:  Annu Rev Physiol       Date:  1989       Impact factor: 19.318

3.  Rapid inhibition of c-myc gene expression by a glucocorticoid in the avian oviduct.

Authors:  C Rories; C K Lau; K Fink; T C Spelsberg
Journal:  Mol Endocrinol       Date:  1989-06

4.  Nerve growth factor induces the proto-oncogene c-jun in PC12 cells.

Authors:  B Y Wu; E J Fodor; R H Edwards; W J Rutter
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

5.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.

Authors:  L Pertovaara; L Sistonen; T J Bos; P K Vogt; J Keski-Oja; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

6.  Induction of protooncogene c-jun by serum growth factors.

Authors:  K Ryder; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 7.  Growth regulatory peptide production by human breast carcinoma cells.

Authors:  M E Lippman; R B Dickson; E P Gelmann; N Rosen; C Knabbe; S Bates; D Bronzert; K Huff; A Kasid
Journal:  J Steroid Biochem       Date:  1988       Impact factor: 4.292

8.  Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.

Authors:  L C Murphy; H Dotzlaw
Journal:  Mol Endocrinol       Date:  1989-04

9.  Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus.

Authors:  L J Murphy; L C Murphy; H G Friesen
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

10.  Steroid-induced cell proliferation in vivo is associated with increased c-myc proto-oncogene transcript abundance.

Authors:  S A Rempel; R N Johnston
Journal:  Development       Date:  1988-09       Impact factor: 6.868

View more
  3 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

3.  Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.

Authors:  R R Perry; Y Kang; B R Greaves
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.